Liver DiseasesNCT07524699
A Study About Remote and Local Liver Surgery
A study testing Remote Liver Surgery and Local Liver Surgery in people with Liver Diseases, run by Tongji Hospital at 1 site in China.
Trial summary
The goal of this clinical trial is to learn if the robotic surgical system producted by Shenzhen Edge Medical Company has a non-inferior textbook outcome in liver surgery in the field of remote surgery compared to local robotic surgery. It will also learn about the safety of remote liver surgery. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Liver Diseases
- What is being tested?
- Remote Liver Surgery and Local Liver Surgery
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 148 participants
- Where
- 1 siteChina
- Study dates
- 16 May 2026to 31 Jul 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age range: 18-75 years old (inclusive), gender not restricted;
- BMI: 18-30 Kg/m2;
- Relevant indications for liver surgery;
- Physiological condition allows for laparoscopic surgery, and the Iwate score for laparoscopic difficulty of the enrolled patients is ≤ 6;
- Willing to cooperate and complete follow-up and related subsequent examinations;
- Voluntary to sign the informed consent form;
- Indocyanine green 15-minute retention rate (ICG-R15) < 15%, and liver function Child-Pugh grade is A.
Who cannot join
- Patients with severe circulatory system diseases who cannot tolerate surgery;
- Pregnant or lactating women;
- Patients with a history of epilepsy or mental illness;
- Patients with severe allergic constitution and those suspected or diagnosed with alcohol or drug addiction;
- Patients who cannot understand the research requirements or who cannot complete the research follow-up;
- Patients considered unsuitable to participate in this trial by the researchers.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430030
Peng Zhu, Medicine Doctor, +86-13907170712, zhupeng@medmail.com.cn
About this study
Official title: Efficacy and Safety of MP1000 System in Remote and Local Liver Surgery: A Prospective, Multicenter, Single-blind, Randomized Controlled Trial
The goal of this clinical trial is to learn if the robotic surgical system producted by Shenzhen Edge Medical Company has a non-inferior textbook outcome in liver surgery in the field of remote surgery compared to local robotic surgery. It will also learn about the safety of remote liver surgery.
The main questions are: Does remote liver surgery not lower the textbook outcomes in liver surgery compared to the local robotic surgery? What complications do participants have when taking remote liver surgery? Investigators will compare remote liver surgery to local robotic liver surgery to see if remote liver surgery doesn't lower the textbook outcome in liver surgery.
Read more
Participants will:
Undergo remote or local robotic liver surgery according to the random program; Visit the clinic in 3, 28 and 42 day after surgery for checkups and tests; Keep a diary of their postoperative complications.
Read the detailed description
(1) Background
Surgery is an important mean to treat diseases. In recent years, surgical techniques have been developing, evolving from initial open surgery and minimally invasive laparoscopic surgery to current robotic surgery. Surgical robotic systems have been applied in clinical practice for over 20 years and got many excellent results. Compared to traditional laparoscopic surgery, robotic surgery show the following advantages:
- Provide the surgeons with high-definition and three-dimensional views;
- The surgical instruments can simulate the flexibility of human fingers and eliminate unnecessary tremors;
- Surgeons use the control consoles to operate devices like open surgery, which doesn't require long-term learning and training;
- The surgeons can independently control the endoscopes and surgical instruments, reducing the need of surgical team members and making it easier to achieve the surgeons' intentions;
- The surgeons operate the systems in sitting positions, which is more easy to perform complex and long time surgery and prolongs the surgeons' surgical life;
- Patients benefit greatly from this new surgical method for smaller incisions, shorter recovery time, and fewer hospital days.
Shenzhen Edge Medical Company has solved many core technologies of robotic surgical system (such as master-slave control strategies, kinematics research, multi-degree-of-freedom simulation manipulators and stereoscopic vision). Beijing Medical Device Inspection Institute has completed the product performance inspection and safety inspection for MP1000 system.
MP1000 system has completed clinical trials for urology, gynecology, general surgery and thoracic surgery, with a 100% success rate in surgeries. Currently, MP1000 system has been approved by the National Medical Products Administration (NMPA). Edge Cloud® remote surgery system also had approved by NMPA in November 2025, with the registration number of 20253011753.
(2) Practical foundation The development of surgical robot technology and remote communication technology promote the possibility of realizing real-time remote surgery. It allows experts to directly control the surgical robot system to perform surgery from a distance of thousands of kilometers with almost no delay. After rigorous and comprehensive technical verification of remote technology and hundreds of animal experiments, it was initially proved that remote surgery was feasible, safe and effective. With the help of Edge remote surgery team, Dr. Zhang Xu, who was from the General Hospital of the People's Liberation Army, successfully performed remote posterior vena cava ureter repair and formation surgery, radical nephrectomy, partial nephrectomy, radical prostatectomy, and adrenal tumor resection surgery between Beijing and Sanya with a distance of 3,000 kilometers. All surgeries were completed successfully with clear surgical views, flexible robotic arm movements, and without signal delaying. It proved the safety and efficacy of remote surgery. Subsequently, the team of Dr. Zhang Xu successfully completed a randomized controlled clinical trial of local and remote nephrectomy and radical prostatectomy in five locations, including Beijing, Hangzhou, Hefei, Harbin, and Urumqi. The trial confirmed that remote surgery was non-inferior to local surgery in terms of surgical success rate, and there were no significant differences in complications, postoperative recovery, incisal margins, and medical team workloads.
In 2025, the team of Chen Xiaoping from the Department of Hepatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, successfully completed 6 remote liver surgery between Wuhan and Guiyang, spanning a distance of 1,200 kilometers. All surgeries were completed successfully and the trial achieved the expected goal, which preliminarily proved the feasibility and safety of remote liver surgery.
However, compared with local liver resection, the issue of whether remote liver resection is non-inferior to local liver resection still needs further research.
(3) Practical significance Remote surgery can reduce the difficulty of patients seeking medical treatment in different places and balance the differences of medical level in different regions. It also can provide high-level medical resources in emergencies.
(4) Product Structure This system consists of three subsystems: a surgical robot subsystem, a communication subsystem, and a remote conference subsystem. The robot subsystem includes a main doctor control console at the hospital where the surgeon locates, and a bedside control system in the patient's operating room. For safety considerations, a spare doctor control console is set up at the patient's side operating room. In case of a failure of the remote surgery system, the surgeon at the patient's side will take over the surgery and complete the subsequent steps. The communication subsystem consists of routers and communication lines. The remote conference subsystem is responsible for transmitting video and audio between the surgeon and the assistant doctor. All video and audio of the remote surgery are recorded by the subsystem. The video of the local surgery will also be recorded.
(5) Working Principle During the surgery, the specialized instruments and endoscope will enter the human body through the channels and reach the surgical area. The image processing platform processes the image signals converts them into stereoscopic image signals. The surgeon at the doctor control console operates the surgical instruments based on the stereoscopic images. The master-slave control system processes the doctor's action signals, then controls the surgical instruments to simulate the surgeon's hand movements and controls the energy excitation of the high-frequency generator connected to the active surgical instruments. The assistant surgeon at the patient's position adjusts the equipment posture, loads and replaces the surgical instruments, loads the endoscope, transmits surgical items, and handles some unexpected emergencies according to the actual clinical needs. The remote surgery is connected to the two robot systems through the remote control platform, using a private network, 5G or broadband network to transmit signals. The surgical doctor controls the local surgical platform at the remote doctor control console to perform the surgery for the patient, while achieving real-time communication between the local end and the remote end. The local doctor control console is connected to the patient's surgical platform and can manually obtain control rights, or automatically obtain control rights in case of remote abnormalities to ensure the completion of the surgery.
(6) Emergency Plan For the risks of the control group (the local surgery group), it has been determined that they are not higher than the risk level of conventional medical care. However, the experimental group (the remote surgery group) may have the risks of system failure due to a more complex structure.
- Remote network anomalies (including abnormal image signals, control instructions, etc.) If the remote network fails and cannot be restored in time, based on the acutal condition, the surgeon beside the patient will decide whether to convert to local surgery.
- Intraoperative operation anomalies (including unsuccessful hemostasis, unprecise operation, etc.) If the network is normal but cannot be effectively handled the remote end, according to the acutal condition, the surgeon beside the patient should promptly decide whether to convert to local surgery.
- Remote surgery protection strategy One surgical control console is set up on the remote side and another on the patient side. The backup surgical control console will be used in case of remote surgery system failure and can be used by the surgeon on the patient side to complete all surgical steps.
The remote surgery system has been updated based on previous practices and data. The system will monitor real-time network latency. When the network latency exceeds 200 ms, the surgical robot will be locked and the technical team will promptly check the system and network status.
(7) Experiment Objective Through this clinical trial, it will evaluate that the MP1000 system has a non-inferior textbook outcome in liver surgery in the field of remote surgery compared to local robotic surgery.
(8) Surgical procedures After the remote surgical system is connected, it is necessary to check whether the network bandwidth for data traffic transmission detection is stable and sufficient. The patient would be placed in a supine position (for left hemihepatectomy, left lateral lobectomy, resection of segment 5, regional lymphadenectomy, and biliary exploration, etc.). The camera port was positioned on the upper side of the umbilicus. Subsequently, a carbon dioxide pneumoperitoneum was established and the pressure was maintained at 12 mmHg. The robotic surgical system was docked on the left side of the patient, and the surgical instruments were installed accordingly. Routine abdominal exploration and intraoperative ultrasound examination were carried out. During the procedure, the Pringle's maneuver clamping was routinely performed. An ultrasonic scalpel was used to perform liver parenchymal transection and ligated or clipped any vessels >2 mm and bile ducts. After hemostasis, the specimen was extracted and one or more drainage tubes were placed on the surface of the raw liver. The surgical team consisted of two surgeons. One served as the console surgeon in the remote end, while the other, the assistant surgeon, was responsible for tasks such as exchanging robotic instruments, delivering surgical supplies, and extracting the specimen in the local end. A spare console was prepared to address potential situations such as communication interruptions, uncontrolled bleeding, or failure of the main console.
(9) Evaluation methods
- Main evaluation indicators: Textbook outcome in liver surgery
- Secondary evaluation indicators 1) Surgical success rate; 2) Overall functional recovery: 15-item recovery quality scores (QoR-15 scores); 3) Physical activity: 30-second standing up test from a sitting position ; 4) Patient pain score; 5) Surgery-related factors: surgery time, console time, installation time, intraoperative blood loss, intraoperative red blood cell transfusion situation, intraoperative complication; 6) Postoperative conditions: Postoperative complication, postoperative hospital stay days.
- Conditions
- Liver Diseases
- Being tested
- Remote Liver Surgery, Local Liver Surgery
- Keywords
- Remote Surgery, Liver Surgery, Randomized controlled trial
- Medical subject headings
- Liver Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Remote Liver SurgeryDevice
The patients in this arm will undergo remote liver surgery.
Local Liver SurgeryDevice
The patients in this arm will undergo local liver surgery.
| Study group | Role | What they receive |
|---|---|---|
| Local Surgery | Active comparator | The patients in this arm (group) will undergo local liver surgery according to random allocation. Receives: Device: Local Liver Surgery |
| Remote Surgery | Experimental | The patients in this arm (group) will undergo remote liver surgery according to random allocation. Receives: Device: Remote Liver Surgery |
What is being measured
The primary outcome is the main question the study is designed to answer.
Textbook outcome in liver surgery
The textbook outcome in liver surgery is defined as the absence of intraoperative incidents of grade 2 or higher (defined according to the Oslo classification), postoperative bile leak of grade B or C (according to the severity grading of the International Study Group of Liver Surgery),30 severe complications (Clavien-Dindo grade III or higher), postoperative reintervention (ie, surgical, endoscopic, or radiologic), readmission within 30 days after discharge, in-hospital mortality, and the presence of R0 resection margin (ie, 1 mm or more tumor-free margin).
Measured: 6 weeks
Secondary outcomes (17)
Surgery Success rate
The number of subjects who successfully completed remote surgical treatment using the experimental equipment, as a proportion of the total number of subjects. The definition of a successful surgery: (a) The surgical process was completed according to the original plan; (b) There was no conversion of surgical methods, such as remote-local, remote-laparoscopic/open; (c) There was no delay due to failure of the surgical system. Whether each case was successful should be confirmed by the medical team after the surgery based on the pre-set criteria for judgment.
Measured: 1 day
Overall complication rate
Measured: 6 weeks
Operation Time
Measured: During surgery
Console Time
Measured: During surgery
Blood loss
Measured: During surgery
Positive Margin rate
This outcome is judged by a pathologist. For the time constraints for preparing the pathological slides, the result usually will be available in one week after the surgery.
Measured: In one week after surgery
Patient pain score
The pain score is from 0 to 10. Score 0 means no pain and score 10 means the most intense pain. Score 1-3 means mild pain and does not affects sleeping. Score 4-6 means moderate pain and may affect sleeping. Score 7-10 means severe pain and seriously affects sleeping and quality of life. A higher score means a worse result.
Measured: 6 weeks
Doctor satisfaction
Doctor satisfaction consists of 6 outcomes: 1) mental demands, 2) physical demands, 3) temporal demands, 4) performance, 5) effort and 6) difficulty. All the score are from 1 to 21. Score 1 means very low and score 21 means very high. The higher score in the result means more needs or difficulty in this evaluation. A higher score means a worse result.
Measured: 1 week
Postoperative hospital stay
Measured: 4 weeks
Blood transfusion rate
Measured: 6 weeks
Readmission rate
Measured: 6 weeks
Reoperation rate
Measured: 6 weeks
Mortality
Measured: 6 weeks
Incidence of device defects
Measured: 6 weeks
Incidence of adverse events
Measured: 6 weeks
Incidence of serious adverse events
Measured: 6 weeks
Remote operation evaluation
The evaluations includes latency and stability evaluation, interaction evaluation, endoscopic image evaluation and operational stability evaluation. Every subevaluation score is from 1 to 5. Score 5: Very satisfied, meeting all clinical needs. Score 4: Quite satisfied, meeting most clinical needs. Score 3: Score 3: basically satisfied, meeting the minimum clinical needs. Score 2: Quite unsatisfied, unable to meet the minimum clinical needs. Score 1: Very unsatisfied, completely unable to operate. The higher score means more satisfaction to the subevaluation and a better outcome.
Measured: In one week after surgery.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Apr 2026
- Study start16 May 2026 (estimated)
- Primary completion31 Dec 2027 (estimated)
- Study completion31 Jul 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Liver DiseasesStudies of the same condition, open and under way.
- More trials run by Tongji HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Double blind
- Who is masked
- Participant, Care provider
- Enrolment
- 148 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tongji Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- The First Medical Center of Chinese PLA General Hospital, The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Affiliated Hospital of Qinghai University, First Affiliated Hospital of Harbin Medical University, Second Affiliated Hospital of Army Medical University, Wuhan TongJi Hospital, Zhujiang Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, First Affiliated Hospital of Chengdu Medical College
- Responsible party
- Principal investigator, Chen Xiaoping, Tongji Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07524699
- Sponsor's protocol ID
- Remote Liver Surgery-1
- Status last verified
- Mar 2026
- First submitted
- 28 Mar 2026
- Last updated
- 18 May 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: If the readers want to learn more about the study, please send an e-mail to Doctor Peng Zhu.
Study at a glance
From the registry record, last updated by the sponsor on 18 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy and Safety of MP1000 System in Remote and Local Liver Surgery: A Prospective, Multicenter, Single-blind, Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07524699
- Acronym / sponsor ID
- Remote Liver Surgery-1
- Conditions
- Liver Diseases
- Keywords
- Remote Surgery, Liver Surgery, Randomized controlled trial
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 148 participants (estimated)
- Lead sponsor
- Tongji HospitalUniversity, hospital or other
- Collaborators
- The First Medical Center of Chinese PLA General Hospital, The First Affiliated Hospital of Anhui Medical University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Affiliated Hospital of Qinghai University, First Affiliated Hospital of Harbin Medical University, Second Affiliated Hospital of Army Medical University, Wuhan TongJi Hospital, Zhujiang Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, First Affiliated Hospital of Chengdu Medical College
- Study start
- 16 May 2026 (estimated)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 31 Jul 2028 (estimated)
- First posted
- 13 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this clinical trial is to learn if the robotic surgical system producted by Shenzhen Edge Medical Company has a non-inferior textbook outcome in liver surgery in the field of remote surgery compared to local robotic surgery. It will also learn about the safety of remote liver surgery.
The main questions are: Does remote liver surgery not lower the textbook outcomes in liver surgery compared to the local robotic surgery? What complications do participants have when taking remote liver surgery? Investigators will compare remote liver surgery to local robotic liver surgery to see if remote liver surgery doesn't lower the textbook outcome in liver surgery.
Participants will:
Undergo remote or local robotic liver surgery according to the random program; Visit the clinic in 3, 28 and 42 day after surgery for checkups and tests; Keep a diary of their postoperative complications.
Detailed description
(1) Background
Surgery is an important mean to treat diseases. In recent years, surgical techniques have been developing, evolving from initial open surgery and minimally invasive laparoscopic surgery to current robotic surgery. Surgical robotic systems have been applied in clinical practice for over 20 years and got many excellent results. Compared to traditional laparoscopic surgery, robotic surgery show the following advantages:
- Provide the surgeons with high-definition and three-dimensional views;
- The surgical instruments can simulate the flexibility of human fingers and eliminate unnecessary tremors;
- Surgeons use the control consoles to operate devices like open surgery, which doesn't require long-term learning and training;
- The surgeons can independently control the endoscopes and surgical instruments, reducing the need of surgical team members and making it easier to achieve the surgeons' intentions;
- The surgeons operate the systems in sitting positions, which is more easy to perform complex and long time surgery and prolongs the surgeons' surgical life;
- Patients benefit greatly from this new surgical method for smaller incisions, shorter recovery time, and fewer hospital days.
Shenzhen Edge Medical Company has solved many core technologies of robotic surgical system (such as master-slave control strategies, kinematics research, multi-degree-of-freedom simulation manipulators and stereoscopic vision). Beijing Medical Device Inspection Institute has completed the product performance inspection and safety inspection for MP1000 system.
MP1000 system has completed clinical trials for urology, gynecology, general surgery and thoracic surgery, with a 100% success rate in surgeries. Currently, MP1000 system has been approved by the National Medical Products Administration (NMPA). Edge Cloud® remote surgery system also had approved by NMPA in November 2025, with the registration number of 20253011753.
(2) Practical foundation The development of surgical robot technology and remote communication technology promote the possibility of realizing real-time remote surgery. It allows experts to directly control the surgical robot system to perform surgery from a distance of thousands of kilometers with almost no delay. After rigorous and comprehensive technical verification of remote technology and hundreds of animal experiments, it was initially proved that remote surgery was feasible, safe and effective. With the help of Edge remote surgery team, Dr. Zhang Xu, who was from the General Hospital of the People's Liberation Army, successfully performed remote posterior vena cava ureter repair and formation surgery, radical nephrectomy, partial nephrectomy, radical prostatectomy, and adrenal tumor resection surgery between Beijing and Sanya with a distance of 3,000 kilometers. All surgeries were completed successfully with clear surgical views, flexible robotic arm movements, and without signal delaying. It proved the safety and efficacy of remote surgery. Subsequently, the team of Dr. Zhang Xu successfully completed a randomized controlled clinical trial of local and remote nephrectomy and radical prostatectomy in five locations, including Beijing, Hangzhou, Hefei, Harbin, and Urumqi. The trial confirmed that remote surgery was non-inferior to local surgery in terms of surgical success rate, and there were no significant differences in complications, postoperative recovery, incisal margins, and medical team workloads.
In 2025, the team of Chen Xiaoping from the Department of Hepatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, successfully completed 6 remote liver surgery between Wuhan and Guiyang, spanning a distance of 1,200 kilometers. All surgeries were completed successfully and the trial achieved the expected goal, which preliminarily proved the feasibility and safety of remote liver surgery.
However, compared with local liver resection, the issue of whether remote liver resection is non-inferior to local liver resection still needs further research.
(3) Practical significance Remote surgery can reduce the difficulty of patients seeking medical treatment in different places and balance the differences of medical level in different regions. It also can provide high-level medical resources in emergencies.
(4) Product Structure This system consists of three subsystems: a surgical robot subsystem, a communication subsystem, and a remote conference subsystem. The robot subsystem includes a main doctor control console at the hospital where the surgeon locates, and a bedside control system in the patient's operating room. For safety considerations, a spare doctor control console is set up at the patient's side operating room. In case of a failure of the remote surgery system, the surgeon at the patient's side will take over the surgery and complete the subsequent steps. The communication subsystem consists of routers and communication lines. The remote conference subsystem is responsible for transmitting video and audio between the surgeon and the assistant doctor. All video and audio of the remote surgery are recorded by the subsystem. The video of the local surgery will also be recorded.
(5) Working Principle During the surgery, the specialized instruments and endoscope will enter the human body through the channels and reach the surgical area. The image processing platform processes the image signals converts them into stereoscopic image signals. The surgeon at the doctor control console operates the surgical instruments based on the stereoscopic images. The master-slave control system processes the doctor's action signals, then controls the surgical instruments to simulate the surgeon's hand movements and controls the energy excitation of the high-frequency generator connected to the active surgical instruments. The assistant surgeon at the patient's position adjusts the equipment posture, loads and replaces the surgical instruments, loads the endoscope, transmits surgical items, and handles some unexpected emergencies according to the actual clinical needs. The remote surgery is connected to the two robot systems through the remote control platform, using a private network, 5G or broadband network to transmit signals. The surgical doctor controls the local surgical platform at the remote doctor control console to perform the surgery for the patient, while achieving real-time communication between the local end and the remote end. The local doctor control console is connected to the patient's surgical platform and can manually obtain control rights, or automatically obtain control rights in case of remote abnormalities to ensure the completion of the surgery.
(6) Emergency Plan For the risks of the control group (the local surgery group), it has been determined that they are not higher than the risk level of conventional medical care. However, the experimental group (the remote surgery group) may have the risks of system failure due to a more complex structure.
- Remote network anomalies (including abnormal image signals, control instructions, etc.) If the remote network fails and cannot be restored in time, based on the acutal condition, the surgeon beside the patient will decide whether to convert to local surgery.
- Intraoperative operation anomalies (including unsuccessful hemostasis, unprecise operation, etc.) If the network is normal but cannot be effectively handled the remote end, according to the acutal condition, the surgeon beside the patient should promptly decide whether to convert to local surgery.
- Remote surgery protection strategy One surgical control console is set up on the remote side and another on the patient side. The backup surgical control console will be used in case of remote surgery system failure and can be used by the surgeon on the patient side to complete all surgical steps.
The remote surgery system has been updated based on previous practices and data. The system will monitor real-time network latency. When the network latency exceeds 200 ms, the surgical robot will be locked and the technical team will promptly check the system and network status.
(7) Experiment Objective Through this clinical trial, it will evaluate that the MP1000 system has a non-inferior textbook outcome in liver surgery in the field of remote surgery compared to local robotic surgery.
(8) Surgical procedures After the remote surgical system is connected, it is necessary to check whether the network bandwidth for data traffic transmission detection is stable and sufficient. The patient would be placed in a supine position (for left hemihepatectomy, left lateral lobectomy, resection of segment 5, regional lymphadenectomy, and biliary exploration, etc.). The camera port was positioned on the upper side of the umbilicus. Subsequently, a carbon dioxide pneumoperitoneum was established and the pressure was maintained at 12 mmHg. The robotic surgical system was docked on the left side of the patient, and the surgical instruments were installed accordingly. Routine abdominal exploration and intraoperative ultrasound examination were carried out. During the procedure, the Pringle's maneuver clamping was routinely performed. An ultrasonic scalpel was used to perform liver parenchymal transection and ligated or clipped any vessels >2 mm and bile ducts. After hemostasis, the specimen was extracted and one or more drainage tubes were placed on the surface of the raw liver. The surgical team consisted of two surgeons. One served as the console surgeon in the remote end, while the other, the assistant surgeon, was responsible for tasks such as exchanging robotic instruments, delivering surgical supplies, and extracting the specimen in the local end. A spare console was prepared to address potential situations such as communication interruptions, uncontrolled bleeding, or failure of the main console.
(9) Evaluation methods
- Main evaluation indicators: Textbook outcome in liver surgery
- Secondary evaluation indicators 1) Surgical success rate; 2) Overall functional recovery: 15-item recovery quality scores (QoR-15 scores); 3) Physical activity: 30-second standing up test from a sitting position ; 4) Patient pain score; 5) Surgery-related factors: surgery time, console time, installation time, intraoperative blood loss, intraoperative red blood cell transfusion situation, intraoperative complication; 6) Postoperative conditions: Postoperative complication, postoperative hospital stay days.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Double blind (participant, care provider)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Local Surgery | Active comparator | Device: Local Liver SurgeryThe patients in this arm (group) will undergo local liver surgery according to random allocation. |
| Remote Surgery | Experimental | Device: Remote Liver SurgeryThe patients in this arm (group) will undergo remote liver surgery according to random allocation. |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Age range: 18-75 years old (inclusive), gender not restricted;
- BMI: 18-30 Kg/m2;
- Relevant indications for liver surgery;
- Physiological condition allows for laparoscopic surgery, and the Iwate score for laparoscopic difficulty of the enrolled patients is ≤ 6;
- Willing to cooperate and complete follow-up and related subsequent examinations;
Key exclusion criteria (6 listed)
- Patients with severe circulatory system diseases who cannot tolerate surgery;
- Pregnant or lactating women;
- Patients with a history of epilepsy or mental illness;
- Patients with severe allergic constitution and those suspected or diagnosed with alcohol or drug addiction;
- Patients who cannot understand the research requirements or who cannot complete the research follow-up;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Remote Liver SurgeryThe patients in this arm will undergo remote liver surgery. | Device | Remote Surgery |
| Local Liver SurgeryThe patients in this arm will undergo local liver surgery. | Device | Local Surgery |
Primary outcome
Textbook outcome in liver surgery
Time frame: 6 weeks
The textbook outcome in liver surgery is defined as the absence of intraoperative incidents of grade 2 or higher (defined according to the Oslo classification), postoperative bile leak of grade B or C (according to the severity grading of the International Study Group of Liver Surgery),30 severe complications (Clavien-Dindo grade III or higher), postoperative reintervention (ie, surgical, endoscopic, or radiologic), readmission within 30 days after discharge, in-hospital mortality, and the presence of R0 resection margin (ie, 1 mm or more tumor-free margin).
17 secondary outcomes
Surgery Success rate
Time frame: 1 day
Overall complication rate
Time frame: 6 weeks
Operation Time
Time frame: During surgery
Console Time
Time frame: During surgery
Blood loss
Time frame: During surgery
Positive Margin rate
Time frame: In one week after surgery
Patient pain score
Time frame: 6 weeks
Doctor satisfaction
Time frame: 1 week
Postoperative hospital stay
Time frame: 4 weeks
Blood transfusion rate
Time frame: 6 weeks
Readmission rate
Time frame: 6 weeks
Reoperation rate
Time frame: 6 weeks
Mortality
Time frame: 6 weeks
Incidence of device defects
Time frame: 6 weeks
Incidence of adverse events
Time frame: 6 weeks
Incidence of serious adverse events
Time frame: 6 weeks
Remote operation evaluation
Time frame: In one week after surgery.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 18 May 2026.
- Individual participant dataSharing planned: Yes. If the readers want to learn more about the study, please send an e-mail to Doctor Peng Zhu.
Related trials for Liver Diseases
RecruitingPhase 1/2
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
Metastatic Melanoma, Liver Metastases
Not yet recruitingObservational study
A Study of Fatigue, Itching and Daily Activities in People With Primary Biliary Cholangitis Starting Elafibranor
Primary Biliary Cholangitis (PBC)
RecruitingObservational study
Conventional Ultrasound Versus Remote Ultraportable ulTrasound in the Context of Viral Hepatitis
Hepatitis, Teleradiology
Not yet recruitingPhase 3
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Obesity, Metabolic Dysfunction-associated Steatotic Liver Disease
RecruitingPhase 3
Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
Primary Biliary Cirrhosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Remote Liver Surgery and Local Liver Surgery in people with Liver Diseases, run by Tongji Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 18 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Peng Zhu, Medicine Doctor (+86-13907170712, zhupeng@medmail.com.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Textbook outcome in liver surgery (time frame: 6 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2026.